baber/WOPTO huggingface dataset:
Patent AT-E256934-T1 (AT)
Inventor: SORRELLS DAVID F
IPC: H03C1/00
Filed: 1999-10-18
Granted: 2004-01-15
Abstract: A method and system is described wherein a signal with a lower frequency is up-converted to a higher frequency. In one embodiment, the higher frequency signal is used as a stable frequency and phase reference. In another embodiment, the invention is used as a transmitter. The upconversion is accomplished by controlling a switch with an oscillating signal, the frequency of the oscillating signal being selected as a sub-harmonic of the desired output frequency. When the invention is being used as a frequency or phase reference, the oscillating signal is not modulated, and controls a switch that is connected to a bias signal. When the invention is being used in the frequency modulation (FM) or phase modulation (PM) implementations, the oscillating signal is modulated by an information signal before it causes the switch to gate the bias signal. In the amplitude modulation implementation (AM), the oscillating signal is not modulated, but rather causes the switch to gate a reference signal that is substantially equal to or proportional to the information signal. In the FM and PM implementations, the signal that is output from the switch is modulated substantially the same as the modulated oscillating signal. In the AM implementation, the signal that is output from the switch has an amplitude that is a function of the information signal. In both embodiments, the output of the switch is filtered, and the desired harmonic is output.
Patent AT-E230554-T1 (AT)
Inventor: KODIM WALTER
IPC: H05K1/18
Filed: 1999-10-28
Granted: 2003-01-15
Abstract: The invention relates to an electrical component (CO) as well as a device (DEV) comprising such an electrical component (CO) and an electric circuit module (MO). A ground plane (4) of the component (CO) and a ground plane (2) of the circuit module (MO) are brought into contact via projections (4'') provided on the ground plane (4) of the component (CO) and/or on the ground plane of the circuit module (MO). The provision of the projections (4'') and the recesses (4') therebetween provide heat sinks between the projections (4'') when they are soldered to the ground plane (2) of the circuit module (MO). Through-holes (8') and additional non-ground conductors (2') can be provided between pads (14) of the ground plane (2) of the circuit module (MO) allowing an efficient use of the available space. The invention is particularly useful when a patch antenna needing a large ground plane is connected to a multilayer circuit board. Another embodiment of the invention comprises a plurality of spacer elements which are arranged between the ground planes (2, 4) of the circuit module (MO) and of the component (CO), such that the ground planes (2, 4) can be kept flat. This allows a design of the configuration of the ground plane of the circuit module (MO) independently from a configuration of the component (CO). <IMAGE>
Patent DE-48207-T1 (DE)
IPC: F24S20/20
Filed: 1981-09-14
Abstract: 1. Process for improving the value of practically pure alpha and beta acids obtained from a highly purified hops extract, particularly by treatment by liquid carbon dioxide, the alpha and beta acids obtained being, if necessary, separated by chromatography on a column of silica or of ion exchange resins comprising hydroxyl groups, then subjected to photoconversion by sunlight, characterised in that said photoconversion is effected by filtration of the sunlight in the wave length comprised between 300 and 400 nm, by concentration of the solar radiation by means of a collector suitable to obtain a light intensity at least equal to Ia = 9.6 x 10**-5 kilowatts/liter and by maintaining the photoisomerisation reaction, at a substantially constant temperature, close to 60 degrees C, so as to obtain an optical quantitative yield.
Patent DE-774045-T1 (DE)
Inventor: DORSCH GLENN
IPC: F04D7/04
Filed: 1994-10-19
Abstract: Stationary cutter teeth project axially inward into the bowl of a centrifugal pump and cooperate with edge portions of the pump impeller vanes at the closed side of the pump bowl for chopping solid matter in the material being pumped.
Patent ES-2170738-T1 (ES)
Title: Procedimiento y aparato para dividir un conducto en compartimientos.
Inventor: ALLEN JERRY
IPC: H02G3/04
Filed: 2000-06-21
Abstract: Aparato para dividir un conducto que se extiende longitudinalmente en compartimientos que comprenden una inserción que se extiende longitudinalmente, estando la inserción formada por al menos dos capas de un material flexible, teniendo dichas capas bordes laterales y uniéndose una a la otra en la proximidad de los bordes laterales para formar al menos un compartimiento entre dichas capas.
Patent ES-2030644-T1 (ES)
Title: Suelo deformable para el paso de objetos pesados entre vehiculos de transportes ferroviarios o de carretera.
IPC: B61D3/18
Filed: 1990-02-05
Abstract: SUELO DEFORMABLE (6) QUE ASEGURA LA CONTINUIDAD DE RODADURA ENTRE DOS VEHICULOS DE UN TREN DE TRANSPORTE PARA LOS EJES DE CARGA ELEVADA DE VEHICULOS TRANSPORTADOS, FORMADOS POR VIGAS YUXTAPUESTAS, ARTICULADAS EN TORNO A UN EJE HORIZONTAL (9) POR ARTICULACIONES ELASTICAS (15), ALVEOLADAS, CON UN GRAN MOVIMIENTO TRANSVERSAL Y CON UN SOPORTE DESLIZANTE SOBRE UN CALZO DE APOYO (12) EN UNA CAVIDAD (8) DEL VEHICULO DE TRANSPORTE QUE EN FRENTE DEL SUELO ES PROLONGADO POR UN PEINDE DE RECUBRIMIENTO (7).
Patent ES-2032736-T1 (ES)
IPC: A23G4/00
Filed: 1991-06-14
Abstract: Chewing gum formed into three-gram strips each including no more than 0.4 mg of nicotine is described. The chewing gum is effective in helping smokers to give up smoking.
Patent CY-1108007-T1 (CY)
Title: Φαρμακευτικες συνθεσεις βοτουλινικης τοξινης
Inventor: HUNT TERRENCE J
IPC: A61K47/16
Filed: 2007-03-26
Abstract: Η παρούσα εφεύρεση αφορά σε φαρμακευτικές συνθέσεις που περιλαμβάνουν (α) μια βοτουλινική τοξίνη, και (β) μια ανασυνδυασμένη αλβουμίνη ανθρώπινου ορού.
Patent CY-1107472-T1 (CY)
Inventor: TEGTMEIER FRANK
IPC: A61K31/55
Filed: 2007-11-14
Abstract: The invention concerns the use of an H1- and/or H2-histamine receptor antagonist for the reduction of intracranial pressure (ICP), in particular for the prevention and treatment of elevated intracranial pressure and/or secondary ischaemia, in particular caused by brain injury, more in particular caused by traumatic (TBI) and non-traumatic brain injury. In particular, the histamine antagonist is selected from the group of acrivastine, alimemazine, antazoline, astemizole, azatadine, azelastine, brompheniramine, buclizine, carbinoxamine, carebastine, cetirizine, chlorcyclizine, chlorpheniramine, cinnarizine, clemastine, clemizole, clocinizine, clonidine, cyclizine, cyproheptadine, descarboethoxyloratidine, dexchlorpheniramine, dimenhydrinate, dimethindene, dimethothiazine, diphenhydramine, diphenylpyraline, doxylamine, ebastine, efletirizine, epinastine, fexofenadine, hydroxyzine, ketotifen, levocabastine, loratidine, meclizine, mequitazine, methdilazine, mianserin, mizolastine, niaprazine, noberastine, norastemizole, oxatomide, oxomemazine, phenbenzamine, pheniramine, picumast, promethazine, pyrilamine, temelastine, terfenadine, trimeprazine, tripelennamine, triprolidine, ranitidine, cimetidine, famotidine, nizatidine, tiotidine, zolantidine, ritanserine, and derivatives thereof and mixtures of any two or more of the foregoing.
Patent CY-1109218-T1 (CY)
Title: Παραγωγα αυτοματης παραγωγης βελτιστοποιημενων κωδικων
Inventor: BODIN FRANÇOIS
IPC: G06F9/45
Filed: 2009-07-15
Abstract: Το σύστημα αυτόματης παραγωγής βελτιστοποιημένων κωδίκων (19) λειτουργικών επί μίας προκαθορισμένης πλατφόρμας υλισμικού (90) που περιλαμβάνει τουλάχιστον έναν επεξεργαστή (91), εκκινώντας από πρωτογενείς κώδικες (17) που υποβάλλονται από τους χρήστες, περιλαμβάνει μέσα (51, 52) λήψεως ακολουθιών συμβολικών κωδίκων ή πρότυπων ακολουθιών (1) που είναι αντιπροσωπευτικές της συμπεριφοράς του επεξεργαστή (91) ως προς τις επιδόσεις, για έναν προκαθορισμένο τομέα εφαρμογής' μέσα (53) λήψεως στατικών παραμέτρων (2), μέσα (55) λήψεως δυναμικών παραμέτρων (7), μία διάταξη αναλύσεως (10) για να καθορίζει κανόνες βελτιστοποιήσεως (9) με βάση δοκιμές και μετρήσεις επιδόσεων που δημιουργούνται εκκινώντας από τις πρότυπες ακολουθίες (1), στατικές παραμέτρους (2) και δυναμικές παραμέτρους (7)· μία διάταξη (80) βελτιστοποιήσεως και παραγωγής κώδικα που δέχεται αφενός τις πρότυπες ακολουθίες (1) και αφετέρου τους κανόνες βελτιστοποιήσεως (9) για να εξετάσει τους πρωτογενείς κώδικες (17) χρηστών, να ανιχνεύσει βελτιστοποιήσιμους βρόχους, να αποσυνθέσει σε πυρήνες και για να συναρμολογήσει και να εγχύσει τους κώδικες κατά τέτοιον τρόπο ώστε να τροφοδοτούνται οι βελτιστοποιημένοι κώδικες (19) και μέσα (74) για να επανεγχύουν πληροφορίες που λαμβάνονται από τη διάταξη (80) βελτιστοποιήσεως και παραγωγής κώδικα και σχετίζονται με τους πυρήνες μέσα στις πρότυπες ακολουθίες (1).
Patent CY-1111175-T1 (CY)
Title: Χειρουργικη κασετα με θαλαμο ρευστου πολλαπλων χωρων
Inventor: HOPKINS MARK A
IPC: A61M5/24
Filed: 2010-11-25
Abstract: Χειρουργική κασέτα που διαθέτει θάλαμο αναρρόφησης ή θάλαμο έγχυσης με τμήμα ανίχνευσης και τμήμα αποθήκευσης. Το τμήμα ανίχνευσης έχει μικρή εγκάρσια διατομή και διευκολύνει την ακριβή μέτρηση στάθμης ρευστού. Το τμήμα αποθήκευσης έχει μεγαλύτερη εγκάρσια διατομή για τη διευκόλυνση της αποθήκευσης ρευστού.
Patent CY-1114546-T1 (CY)
Title: Χρηση παραγωγων κυκλοεξανεξολης στην θεραπευτικη αντιμετωπιση οφθαλμικων νοσων
Inventor: CRUZ ANTONIO
IPC: A61P27/02
Filed: 2013-08-20
Abstract: Η παρούσα εφεύρεση σχετίζεται με μεθόδους θεραπευτικής αντιμετώπισης οφθαλμικών νόσων σε ένα υποκείμενο, χορηγώντας στο υποκείμενο μια θεραπευτικά αποτελεσματική ποσότητα ενός ή περισσότερων παραγώγων κυκλοεξανεξόλης και έναν φαρμακευτικά αποδεκτό φορέα. Ειδικότερα, η εφεύρεση παρέχει ένα φάρμακο που περιέχει τουλάχιστον ένα παράγωγο κυκλοεξανεξόλης του τύπου (III) ή (IV) χρήσιμο στην πρόληψη ή την θεραπευτική αντιμετώπιση οφθαλμικών νόσων, ρυθμίζοντας την πτύχωση, τον ολιγομερισμό ή την συσσωμάτωση του αμυλοειδούς β στα οφθαλμικά κύτταρα. Μέθοδοι χορήγησης αυτών των φαρμάκων περιλαμβάνουν: συστημική, διαπλευρική, από του στόματος, ενδοφλέβια, ενδοαρτηριακή, ενδομυϊκή, τοπική, μέσω εισπνοής, διαδερμική, υποδόρια, ενδοπεριτοναϊκή, γαστρεντερική, και απευθείας στον οφθαλμό ή τους ιστούς που περιβάλλουν τους οφθαλμούς. Τύποι (III) και (IV).
Patent CY-1114979-T1 (CY)
Inventor: JALAN RAJIV
IPC: A61K31/198
Filed: 2014-03-18
Abstract: The present invention relates to use of ornithine in the manufacture of a medicament for use in combination with at least one of phenylacetate and phenylbutyrate for preventing or treating hyperammonemia. The invention also relates to use of at least one of phenylacetate and phenylbutyrate in the manufacture of a medicament for use in combination with ornithine for preventing or treating hyperammonemia.
Patent CY-1115972-T1 (CY)
Title: Διμερικοι ιαρ αναστολεις
Inventor: CONDON STEPHEN M
IPC: A61K31/40
Filed: 2014-04-14
Abstract: Ενώσεις-μιμητές της Smax είναι ικανές να διαμορφώσουν το φαινόμενο της απόπτωσης μέσω της αλληλεπίδρασης τους με κυτταρικές lAPs (αναστολείς πρωτεϊνών απόπτωσης). Οι μιμητικές ενώσεις βασίζονται σε μονομερές ή διμερές του Ν-τερματικού τετραπεπτιδίου πρωτεϊνών ΙΑΡ-δέσμευσης, όπως Smac/DIABLO, Hid, Grim και Reaper, οι οποίες αλληλεπιδρούν με ειδική επιφανειακή αύλακα των ΙΑΡ. Επίσης αποκαλύπτονται μέθοδοι χρήσης αυτών των πεπτιδομιμητικών για θεραπευτικούς σκοπούς. Σε διάφορες υλοποιήσεις της εφεύρεσης οι Smax μιμητικές ενώσεις της εφεύρεσης συνδυάζονται με χημειοθεραπευτικούς παράγοντες, όπως, αλλά όχι περιοριστικά, αναστολείς τοποϊσομεράσης, αναστολείς κινάσης, NSAIDs, ταξάνες και λευκοχρυσιούχες ενώσεις.
Patent CY-1115317-T1 (CY)
Title: Εκλεκτικος ρυθμιστης οιστρογονικου υποδοχεα σε συνδυασμο με δεϋδροεπιανδροστερονη (dhea) ή αναλογα
Inventor: LABRIE FERNAND
IPC: C07D311/60
Filed: 2014-06-23
Abstract: Νέες μέθοδοι για την ιατρική αντιμετώπιση και/ή παρεμπόδιση της ανάπτυξης καρκίνου του μαστού, υπερχοληστερολαιμίας, υπερλιπιδαιμίας ή αθηροσκλήρωσης σε ευπαθή θερμόαιμα ζώα περιλαμβάνοντας ανθρώπους οι οποίες αφορούν χορήγηση εκλεκτικού ρυθμιστή οιστρογονικού υποδοχέα και μιας ποσότητας μιας πρόδρομης ένωσης στεροειδούς του φύλου επιλεγμένης από την ομάδα η οποία αποτελείται από δεϋδροεπιανδροστερόνη, θειική δεϋδροεπιανδροστερόνη, ανδροστ-5-ενο-3β-17β-διόλη και ενώσεις οι οποίες μετατρέπονται in vivo σε μία από τις προαναφερθείσες πρόδρομες ενώσεις. Η περαιτέρω χορήγηση διφωσφονικών σε συνδυασμό με εκλεκτικούς ρυθμιστές οιστρογονικού υποδοχέα και/ή πρόδρομες ενώσεις στεροειδούς του φύλου γνωστοποιείται. Φαρμακευτικές συνθέσεις για παροχή δραστικών συστατικών και κυτία χρήσιμα για την εφεύρεση γνωστοποιούνται.
Patent CY-1118873-T1 (CY)
Title: Φαρμακευτικη δοσολογικη μορφη μιας φαρμακευτικα αποδεκτης ενωσης διαλυτοποιησης
Inventor: Rosenberg Jörg
IPC: A61K47/22
Filed: 2017-02-17
Abstract: Φέρεται στο προσκήνιο μια φαρμακευτικά αποδεκτή σύνθεση διαλυτοποίησης η οποία περιλαμβάνει (i) τουλάχιστον μία ένωση τοκοφερυλίου με χαρακτηριστική ομάδα πολυαλκυλενογλυκόλης και (ii) τουλάχιστον έναν μονοεστέρα λιπαρού οξέος με αλκυλενογλυκόλη ή μίγμα μονοεστέρα και διεστέρα λιπαρού οξέος με αλκυλενογλυκόλη. Η σύνθεση διαλυτοποίησης είναι χρήσιμη στη μεταποίηση προς μια φαρμακευτική δοσολογική μορφή η οποία περιλαμβάνει ένα μίγμα τήγματος τουλάχιστον ενός δραστικού συστατικού, τουλάχιστον ενός φαρμακευτικά αποδεκτού πολυμερούς. Το δραστικό συστατικό ή συστατικά μπορεί να έγκειται σε αναστολέα πρωτεάσης του HIV. Η σύνθεση διαλυτοποίησης ενισχύει τη βιοδιαθεσιμότητα του δραστικού συστατικού κατόπιν πρόσληψης από του στόματος.
Patent CY-1119212-T1 (CY)
Title: Χρηση του odiparcil στη θεραπεια μιας μυκοπολυσακχαριδωσης
Inventor: MASSON PHILIPPE
IPC: A61P43/00
Filed: 2017-08-04
Abstract: Η παρούσα εφεύρεση αφορά στη χρήση του 4-μεθυλ-2-οξο-2Η-1-βενζοπυραν-7-υλ-5-θειο-β-D-ξυλοπυρανοσιδίου στη θεραπεία των μυκοπολυσακχαριδώσεων.
Patent GR-910300067-T1 (GR)
Title: Stator of an electric motor and electric motor having such a stator
Inventor: TRIAN HERVE
IPC: F04D13/06
Filed: 1991-11-15
Abstract: The stator of an electric induction motor comprises a magnetic sheet-metal stack provided with notches in which are accommodated the substantially straight portions of the coil windings of the motor. 
<??>The coil heads or lead-outs 34 are encapsulated at each end of the stator in a closed insulating housing 35, 36, 41; 37, 38, 42, on the end of the metal sheets of the stator in the vicinity of the air gap and on the outside of the yoke 31a of the magnetic circuit of the stator, one of the insulating housings being open over the whole air gap cross section in order to receive the rotor 4 which becomes flanged onto a mount 18 of the rotor whereas the other housing 37, 38, 42 comprises a support flange 43 of the stator on a rotor bearing 7. 
<??>Application to motors with rotor held in position by an air gap tube and in which the stator is removably threaded on the rotor block. 
<IMAGE>
Patent GR-930300012-T1 (GR)
Title: Powdery absorbent, for aqueous liquids, based on water-bulking polymer.
Inventor: BREHM HELMUT
IPC: C08K5/17
Filed: 1993-04-28
Abstract: The invention relates to a powdery absorbent for aqueous liquids, based on a water-swellable powdery polymer having at least 0.2 equivalents of carboxyl groups per 100 parts by weight, of which 50 to 99, advantageously at least 80, mol% are neutralised. The absorbent can be obtained by treating the water-swellable, carboxyl group- containing polymer with a solution of N-hydroxyalkyl- beta -(meth)alanine ester or the polycondensation products thereof. The solvent used for the treatment agent is water, which contains either water-miscible organic diluents, which evaporate on warming of the mixture, or diluents which do not evaporate i.e. remain in the polymer.
Patent GR-940300068-T1 (GR)
Title: Arylalkanoic acid resolution.
Inventor: EVANS CHRISTOPHER THOMAS
IPC: C12P7/44
Filed: 1994-10-31
Abstract: PCT No. PCT/EP92/01892 Sec. 371 Date Jun. 17, 1994 Sec. 102(e) Date Jun. 17, 1994 PCT Filed Aug. 19, 1992 PCT Pub. No. WO93/04189 PCT Pub. Date Mar. 4, 1993.Arylalkanoic acids are produced by biotransformation using suitable microorganisms and, in particular, (S)-ketoprofen in greater than 95% purity from racemic ketoprofen ethyl ester.
Patent GR-980300010-T1 (GR)
Title: Man-made vitreous fibres
Inventor: JENSEN SOREN LUND
IPC: C03C3/087
Filed: 1998-03-31
Abstract: Man-made vitreous fibres have a solubility at pH 4.5 of at least 20nm per day and a melt viscosity of 10-70 poise at 1,400°C. A composition which will provide these properties is selected for their manufacture and contains at least 105 by weight Al<sub>2</sub>O<sub>3</sub>. Novel fibres contain at least 6% by weight Na<sub>2</sub>O + K<sub>2</sub>O.
Patent GR-990300044-T1 (GR)
Title: Fermented beverage with beer wort base, method for preparing same
Inventor: MALCORPS PHILIPPE
IPC: C12H1/14
Filed: 1996-10-31
Abstract: A method of preparing beer from beer wort including adding amidated pectin to the wort or beer to inhibit coagulation and precipitation of proteins and to obtain a haze in the beer.
Patent HR-P20120168-T1 (HR)
Inventor: BOFFELLI PHILIPPE
IPC: A61P3/00
Filed: 2012-02-20
Abstract: Postupak sinteze derivata opće formule (I), u kojoj R, R' i R'', međusobno neovisno, predstavljaju jedan ili više vodika, halogena (Cl, F, Br ili I), cijano, nitro, nerazgranatih ili razgranatih alkila s 1 do 6 atoma ugljika, nerazgranatih ili razgranatih alkoksi s 1 do 6 atoma ugljika, nerazgranatih ili razgranatih alkil-karboksilata s 1 do 6 atoma ugljika, trifluormetilnih ili trifluormetoksi radikala, a R''' predstavlja nerazgranatu ili razgranatu alkilnu ili perfluoralkilnu skupinu s 1 do 6 atoma ugljika ili arilnu skupinu, izborno supstituiranu s jednim ili više radikala R''naznačen time što se sulfonat formule (II), gdje R i R', međusobno neovisno, predstavljaju jedan ili više vodika, halogena (Cl, F, Br ili I), cijano, nitro, nerazgranatih ili razgranatih alkila s 1 do 6 atoma ugljika, nerazgranatih ili razgranatih alkoksi s 1 do 6 atoma ugljika, nerazgranatih ili razgranatih alkil-karboksilata s 1 do 6 atoma ugljika, trifluormetilnih ili trifluormetoksi radikala, a R1 predstavlja metilni, trifluormetilni, C4F9, C8F17 ili fenilni radikal, izborno supstituiran s metilnim, bromnim ili nitro ostatkomkondenzira sa sulfonamidom formule (III), u kojoj R'' predstavlja jedan ili više vodika, halogena (Cl, F, Br ili I), cijano, nitro, nerazgranatih ili razgranatih alkila s 1 do 6 atoma ugljika, nerazgranatih ili razgranatih alkoksi s 1 do 6 atoma ugljika, nerazgranatih ili razgranatih alkil-karboksilata s 1 do 6 atoma ugljika, trifluormetilnih ili trifluormetoksi radikala, a R''' predstavlja nerazgranatu ili razgranatu alkilnu ili perfluoralkilnu skupinu s 1 do 6 atoma ugljika ili arilnu skupinu, izborno supstituiranu s jednim ili više radikala R''u organskom otapalu, izborno u prisutnosti vode, na temperaturi između 20 °C i 150 °C, u prisutnosti mineralne ili organske baze i fazno-transportnog sredstva. Patent sadrži još 15 patentnih zahtjeva.
Patent SI-1480283-T1 (SI)
Title: Battery case
Inventor: PIETZEKATIS KARL-HEINZ
IPC: H01M2/10
Filed: 2004-05-19
Abstract: The battery casing (2) has an elongated opening provided in one flange (6) of the casing for reception of a carrying handle element (7) having an elongate grip section (8) of greater size than the flange opening, provided with a loop section (9) at one end fitted through the flange opening for cooperating with a locking element provided by a projection (10) of the battery casing below the flange opening.
Patent SI-1775507-T1 (SI)
Title: Fitting for pipes
IPC: F16L13/00
Filed: 2005-10-12
Abstract: A pipeline fitting has at least one connector (1) to fit to the end of the pipeline. There are at least two holding ribs (4) round the connector to hold the pipeline end (2) being fitted in or on it. Each holding rib contains at least one axial flow channel (5), the one in one rib being offset from that in the other.
Patent SI-1737451-T1 (SI)
Title: Monocyclic heterocycles as kinase inhibitors
Inventor: BORZILLERI ROBERT M
IPC: C07D413/02
Filed: 2005-04-22
Abstract: The present invention is directed to compounds having the formula and methods for using them for the treatment of cancer.
Patent SI-1968829-T1 (SI)
Title: Automatic vehicle washing unit and process
Inventor: PUGNO VANONI FRANCESCO
IPC: B60S3/00
Filed: 2006-12-15
Abstract: The automatic vehicle washing unit, particularly of the type without brushes, comprises at least one first arched structure ( 2 ) equipped with spray nozzles of at least one first washing agent, below which the vehicle ( 3 ) to be washed can be positioned, support means ( 4 ) of said first arched structure ( 2 ), translation means of said support means ( 4 ) parallel to the principal axis of said vehicle ( 3 ), and first hinging means ( 6 ) of said first arched structure ( 2 ) to said support means ( 4 ) through a first hinging axis ( 7 ) transversal to the direction of translation of said support means ( 4 ).
Patent SI-2251319-T1 (SI)
Title: Process for preparing derivatives of benzoic acid
Inventor: TORISAWA YASUHIRO
IPC: C07C233/00
Filed: 2006-09-01
Abstract: This invention provides a process for preparing benzazepine compounds of the formula (1):   
wherein X 1  is a halogen atom, R 1  and R 2  are a lower alkyl group, or salts thereof as well as intermediate benzoic acid compounds in high yield and high purity on industrial scale, which are useful as an intermediate for preparing a pharmaceutically active 2,3,4,5-tetrahydro-1H-1-benzazepine compound having vasopressin antagonistic activity.
Patent SI-2027152-T1 (SI)
Title: Peptide fragments for inducing synthesis of extracellular matrix proteins
Inventor: HARRIS SCOTT M
IPC: C07K5/00
Filed: 2007-06-12
Abstract: A tetrapeptide comprising SEQ ID NO: 10 (PKGP) or SEQ ID NO: 9 (PEKP) for use as a medicament.  Use of a tetrapeptide comprising SEQ ID NO: 10 (PKGP) or SEQ ID NO: 9 (PEKP) as a cosmetic product.  A pharmaceutical composition for use as a medicament comprising a tetrapeptide comprising SEQ ID NO: 10 (PKGP) or SEQ ID NO: 9 (PEKP) and a pharmaceutical carrier.  An in vitro method for stimulating the production of collagen by a cell, the method comprising exposing a cell to a tetrapeptide comprising SEQ ID NO: 10 (PKGP) or SEQ ID NO: 9 (PEKP) thereby inducing collagen production by the cell.
Patent SI-2306425-T1 (SI)
Title: Device and method for detecting wheel axles
Inventor: NAGY OLIVER
IPC: G08G1/015
Filed: 2009-10-01
Abstract: The device (1) has a sensor (5) operated according to a light-section procedure to emit light (9) from a location along a roadway to project a line of light (10) onto the roadway and a vehicle located on the roadway. The sensor records line of light from next location along the same side of the roadway, and detects wheel axle during exhibition of recorded line of light. The shift-free change of light is realized in the direction different from original direction when the roadway is empty during emanation of light from the side of roadway.
Patent SI-3124018-T1 (SI)
Title: Oral formulations of deferasirox
Inventor: GHOSH INDRAJIT
IPC: A61P39/00
Filed: 2014-03-06
Abstract: Orally administerable deferasirox formulations are disclosed having reduced release under gastric conditions and fast release at near neutral pH or at neutral pH.
Patent TR-200806093-T1 (TR)
Title: Bir soğutucu
Inventor: CELIK RIDVAN KADIR
IPC: F25D25/04
Filed: 2007-03-30
Abstract: Bu buluş, yüksekliği ayarlanabilen bir raf içeren bir soğutucu (1) ile ilgilidir. Söz konusu soğutucuda (1) kullanılan rafın (4) farklı kenarlarında yer alan pimlere (6), bir noktadan kumanda edilebilmektedir. Bunun için, hareket mekanizması (7, 70), tutamağa (8, 80) uygulanan kuvvetin doğrultusunu ve yönünü farklı kenarlarda yer alan pimlere (6) doğru değiştiren bir yönlendirici (9, 90) ve bu yönlendiricinin içinde hareket ederek kuvveti pimlere (6) taşıyan bir kuvvet aktarıcı (11, 110) içermektedir.